The bipartisan Gabriella Miller Kids First Act 2.0 would reauthorize and increase funding for the National Institute of Health’s (NIH) Kids First initiative, which has supported lifesaving research of treatments for childhood cancer and is set to expire in September. Pediatric cancer remains the number one disease that leads to the death of American children. While survival rates have improved for some types of pediatric cancers, thousands of children are lost to cancer each year and many more encounter life threatening complications related to harsh chemotherapies. This program’s foundational research is critical for facilitating a better understanding of pediatric cancers and holds the promise for the development of better treatments and possible cures. As a longtime advocate for children and rare disease patients, I am proud to push for the continuation of this crucial research.
Gus Bilirakis.
